数字认知行为疗法应用与皮治疗失眠的比较:一个探索性随机对照试验的协议
Eiji Shimizu1,2, Daisuke Sato3,4, Yoshiyuki Hirano5
1Departments of Cognitive Behavioral Physiology, Chiba University Graduate School of Medicine School of Medicine, Chiba, Japan eiji@faculty.chiba-u.jp.
BMJ open
|June 26, 2024
概括
本研究方案概述了一项试验,将失眠的数字认知行为疗法 (dCBT) 与佐洛皮相比较. 这项研究旨在评估dCBT.
科学领域:
- 睡眠医学 睡眠医学
- 数字健康数字健康
- 临床试验 临床试验
背景情况:
- 失眠是一种普遍的健康问题,认知行为疗法 (CBT) 是推的治疗方法.
- 由于缺乏训练有素的CBT治疗师,需要采用替代的治疗方法.
- 一个数字CBT应用程序 (dCBT),Sleepy Med,被开发为一种治疗失眠的医疗设备.
研究的目的:
- 描述一个探索性随机对照试验 (RCT) 的协议.
- 评估开发的数字CBT (dCBT) 在5周内治疗失眠的有效性和安全性.
- 在患有失眠障碍的患者中,将dCBT与佐洛皮酸盐进行比较.
主要方法:
- 一个多中心的探索性RCT涉及30名被诊断患有失眠障碍的参与者.
- 参与者将被随机分为两个平行组:dCBT和皮.
- 疗效将在基线,5周 (干预后) 和10周 (随访) 评估.
- 主要结局:第5周主观睡眠开始延迟的变化.
- 二次结果:客观睡眠开始延迟,白天功能改善和生活质量.
主要成果:
- 本节不适用,因为摘要描述的是研究方案,而不是结果.
结论:
- 本研究协议详细介绍了一项探索性RCT,以评估新型数字CBT干预失眠的有效性和安全性.
- 这些发现将有助于理解dCBT作为失眠障碍的可访问治疗选择的潜力.
更多相关视频
相关概念视频
Management of Insomnia
243
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
243
Insomnia
82
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
82
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Sedatives and Hypnotics Drugs: Miscellaneous Agents
167
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
167
Sedatives and Hypnotics Drugs: Benzodiazepines
234
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
234
CNS Depressants: Barbiturates and Benzodiazepines
243
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
243


